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Epidermal dendritic cells found in in£amed skin in-
clude Langerhans cells and the recently identi¢ed popu-
lation of in£ammatory dendritic epidermal cells.
Another subset of dendritic cells in humans is the plas-
macytoid dendritic cell in peripheral blood, which is
characterized by the production of large amounts of
type I interferon (interferon-a and interferon-b) upon
viral infection. We hypothesized that plasmacytoid
dendritic cells might be involved in anti-viral defense
mechanisms of the skin. Here we investigated plasma-
cytoid dendritic cells, in£ammatory dendritic epider-
mal cells, and Langerhans cells in epidermal single cell
suspensions of normal looking skin from healthy
volunteers and of lesional skin from patients with dif-
ferent in£ammatory skin diseases. Langerhans cells
were found in normal and in in£amed skin samples. In
normal skin, plasmacytoid dendritic cells and in£am-
matory dendritic epidermal cells were low or absent.
Lesional skin samples from patients with psoriasis vul-
garis and contact dermatitis contained relatively high
numbers of both in£ammatory dendritic epidermal
cells and plasmacytoid dendritic cells. In contrast,
many in£ammatory dendritic epidermal cells but only
very few plasmacytoid dendritic cells could be detected
in atopic dermatitis lesions. Lupus erythematosus was
characterized by high numbers of plasmacytoid dendri-
tic cells but low numbers of in£ammatory dendritic
epidermal cells. These results demonstrate that in
addition to resident Langerhans cells, plasmacytoid den-
dritic cells and in£ammatory dendritic epidermal cells
are selectively recruited to the skin lesions depending
on the type of skin disease. The lack of plasmacytoid
dendritic cells in atopic dermatitis may predispose ato-
pic dermatitis patients to viral infections such as eczema
herpeticum, a secondary infection of atopic dermatitis
lesions with herpes simplex virus. The composition of
dendritic cell subsets may help to clarify the etiology of
in£ammatory skin diseases and forms the basis for ther-
apeutic intervention with selective microbial molecules
such as immunostimulatory CpG oligonucleotides.
Key words: £uorescence-activated cell sorter/human/plasmacy-
toid dendritic cells. J Invest Dermatol 119:1096 ^1102, 2002
D
endritic cells (DC) link innate and adaptive immu-
nity by their ability to induce appropriate immune
responses upon recognition of invading pathogens,
thus serving as ‘‘nature’adjuvant’’ (Banchereau et al,
2000). The Langerhans cells (Langerhans, 1868)
are the only DC population identi¢ed in normal epidermis
(Banchereau and Steinman, 1998). Langerhans cells are usually lo-
cated in the suprabasal layer of the epidermis where they form
a close network of sentinels that represent a ‘‘¢rst barrier’’ of the
immune system against the environment (Birbeck et al, 1961;
Wollenberg and Bieber, 2002). Langerhans cells constantly moni-
tor the epidermal microenvironment by taking up antigen and
by transporting antigen from the epidermis to regional lymph
nodes, where they initiate T cell responses (Stoitzner et al, 2002).
In contrast to normal skin, which contains only Langerhans
cells, two distinct DC populations have been identi¢ed in in-
£amed epidermis: the classical Langerhans cells containing
Birbeck granules (CD1aþþþ , HLA-DRþþþ , CD11b^), and
the in£ammatory dendritic epidermal cells (IDEC), which
lack Birbeck granules (CD1aþ , HLA-DRþþþ , CD11bþþþ )
(Wollenberg et al, 1996; Bieber et al, 2000). IDEC express costimu-
latory molecules in situ (Schuller et al, 2001), take up mannosy-
lated antigens via mannose receptor-mediated endocytosis
(Wollenberg et al, 2002), and represent the relevant FceRI-expres-
sing and IgE-binding epidermal DC population in atopic derma-
titis (AD) (Wollenberg et al, 1999). Besides IDEC, other types of
DC may enter the skin under certain conditions. The plasmacy-
toid DC (PDC) is a novel DC subset that seems to be specialized
for the detection of viral infection (Cella et al, 1999; Siegal et al,
1999; Galy et al, 2000). Upon viral infection, PDC produce large
amounts of the anti-viral type I interferon (IFN) (IFN-a and
IFN-b) and thus form a key component of the anti-viral defense
strategy of the immune system. The PDC is identical with the
‘‘natural type I IFN producing cell’’ (Cella et al, 1999; Siegal et al,
1999; Galy et al, 2000), which was described many years ago as a
rare CD4þ/major histocompatibility complex (MHC) IIþ popu-
lation [1:1000 within peripheral blood mononuclear cells
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(PBMC)] capable of synthesizing extremely high amounts of
type I IFN upon viral infection (Abb et al, 1983; Chehimi et al,
1989; Fitzgerald-Bocarsly, 1993). Upon maturation this cell type
develops characteristic features of DC (Cella et al, 1999; Siegal
et al, 1999; Kadowaki et al, 2000).
A better understanding of mechanisms that regulate in¢ltra-
tion and function of DC subsets in the skin may lead to new
strategies for therapeutic interventions in order to suppress, sti-
mulate, or deviate cutaneous immune responses. In this study we
analyzed the presence of three human DC subsets (PDC, IDEC,
and Langerhans cells) in skin lesions of patients with di¡erent in-
£ammatory skin diseases by using a newly developed four-color
staining protocol for £ow cytometry, and by using immuno-
histochemistry with the new PDC-speci¢c antibody BDCA-2
(Dzionek et al, 2001).
MATERIALS AND METHODS
Preparation and immunolabeling of epidermal cell suspensions
Following written informed consent, skin biopsies were obtained from
patients of the dermatology clinic, as approved by the local ethics
committee. After local anesthesia, biopsies were taken from chronic
in£ammatory skin lesions, which had not been treated for at least 2 wk.
Biopsies of normal looking human skin obtained from surgical specimens
served as control. Analysis was performed on a total of 26 biopsies: normal
human skin (n¼ 3), AD (n¼ 9), contact dermatitis (CD, n¼ 5), psoriasis
vulgaris (n¼ 7), and lupus erythematosus (LE, n¼ 2). Epidermal single
cell suspensions were prepared by a standardized, limited trypsin diges-
tion technique and ¢ltered through a 50 mm nylon mesh as described in
detail elsewhere (Wollenberg et al, 1999).
Cells were washed and resuspended in phosphate-bu¡ered saline.
Human serum was added to block nonspeci¢c binding of antibodies.
Cells were stained with anti-CD123-phycoerythrin (PE), anti-HLA-DR-
Peridinin-chlorophyll-protein (PerCP), anti-CD11c-allophycocyanin
(APC), and £uorescein isothiocyanate (FITC)-conjugated lineage cocktail
1, consisting of anti-CD3, anti-CD14, anti-CD16, anti-CD19, anti-CD20,
and anti-CD56 (all from Becton Dickinson, Mountain View, CA). In
some experiments, anti-CD1a was used instead of anti-CD123, or cells
were stained with anti-BDCA-2 (Miltenyi Biotec, Bergisch Gladbach,
Germany).
Flow cytometric analysis Flow cytometric data were acquired on a
Becton Dickinson FACSCalibur equipped with two lasers (excitation at
488 and 635 nm wave length). Spectral overlap was corrected by
appropriate compensation. A life gate based on the physical properties of
the cells FSC vs SSC (forward scatter vs side scatter) was set to exclude
cell multiplets from acquisition. Data were analyzed using Cellquest
software (Becton Dickinson).
Immunohistochemical analysis of PDC in skin sections For imm-
unohistochemical staining, tissue specimens were embedded in Tissue tek
(Sakura Finetek, Torrance, CA), cryopreserved in N2 and stored at ^201C.
Acetone-¢xed cryosections (4 mm) were prepared and incubated with the
PDC-speci¢c monoclonal antibody (MoAb) BDCA-2 (Dzionek et al, 2001)
for 1 h at room temperature after blocking endogenous peroxidase activity
with 0.3% H2O2. An IgG1 isotype MoAb was used as negative control.
After incubation with biotinylated horse anti-mouse IgG (1/300, Dako
A/S, Glostrup, Denmark) for 1 h at room temperature, sections were
rinsed and incubated with avidin^biotin peroxidase complex (1/200,
Sigma, Deisenhofen, Germany) for 30 min at room temperature. As a
next step, 0.01% 3-amino-9-ethyl-carbazol in 0.1 M Na-acetate bu¡er
(pH 5,5, 0.0015% H2O2, 6% dimethylsulfoxide) was used as chromogen.
With this procedure, PDC stained red. Other cellular elements were
counterstained with Mayer’ hemalaun (blue).
Statistical analysis Data are expressed as mean7SEM. Statistical
signi¢cance of di¡erences was determined by the Mann^Whitney U test
and the Wilcoxon rank test. Di¡erences were considered statistically
signi¢cant for po0.05. Statistical analyses were performed using StatView
4.51 software (Abacus Concepts Inc., Calabasas, CA).
RESULTS
Identi¢cation of Langerhans cells, IDEC, and PDC in
human skin DC are characterized by the lack of lineage
markers (CD3 for T cells, CD14 for monocytes, CD16 and
CD56 for natural killer cells, CD19 and CD20 for B cells) and
by the expression of MHC II.Within the CD1aþ population in
skin biopsies of patients with in£ammatory skin disease, two DC
subsets can be distinguished based on the expression of CD11b:
Langerhans cells (CD1aþþþ ; CD11b^) and IDEC (CD1aþ ;
CD11bþþþ ). Normal skin contains only Langerhans cells but
no IDEC (Wollenberg et al, 1996, 1999).
In peripheral blood, PDC can be identi¢ed by the expression
of MHC II and CD123 within lineage-negative cells (Krug et al,
2002a). Additional staining with the pan-myeloid marker CD11c
allowed a clear separation of PDC from myeloid DC (Fig 1A).
When the same four-color staining was performed on cells
derived from in£ammatory skin lesions, a population of PDC
could be clearly separated from other DC subsets (Fig 1C). The
identity of PDC was con¢rmed by similar FSC and
SSC characteristics as compared with PDC in peripheral blood
(Fig 1A); as well as by staining with a new PDC-speci¢c
antibody for BDCA-2 (blood DC antigen-2, recently identi¢ed
C-type lectin) (Dzionek et al, 2001), which detected a similar
frequency of PDC as the four-color staining protocol (Fig 2).
In order to identify the other lineage-negative/MHC II-
positive cell subsets, CD123 was replaced by CD1a (Fig 1C,
fourth panel from left). A large proportion of CD11c bright cells
and of CD11c-intermediate or CD11c-low cells were positive for
CD1a suggesting that these cell populations contain Langerhans
cells and IDEC (Fig 1C, fourth panel from left). CD11b but not
the pan-myeloid marker CD11c is an established marker for the
distinction of Langerhans cells and IDEC; therefore, we
compared the expression level of CD11b and CD11c on CD1a-
positive cells (Fig 1B). Like CD11b, CD11c showed a bright
staining of IDEC but was low on Langerhans cells. Thus, like
CD11b, CD11c can be used to separate IDEC from Langerhans
cells within a CD1a-positive population. As (besides a small
proportion of CD11c bright cells) the expression of CD1a and
CD123 was mutually exclusive (within MHC IIþ /lineage cells
of the skin), a four-color staining (lineage, MHC II, CD11c,
CD123) was su⁄cient to simultaneously identify three subsets of
DC in human skin: IDEC (CD11cþþþ ; CD123^), Langerhans
cells (CD11cþ /^; CD123^), and PDC (CD11c^; CD123þþ).
Distinct pro¢le of DC subsets in skin from patients with
di¡erent in£ammatory skin diseases Cells positive for
CD45 and CD123 have been found in skin lesions of patients
with LE by using immunohistologic analysis (Farkas et al, 2001).
To con¢rm the presence of PDC in LE, we performed four-
color £ow cytometry allowing simultaneous detection and
quanti¢cation of PDC, Langerhans cells, and IDEC in single cell
suspensions of skin biopsies. In two di¡erent LE patients, PDC
represented 0.32% and 0.35% of all epidermal cells in lesional
skin. This number of PDC is relatively high considering the
percentage of PDC in peripheral blood (0.2^0.4% of all PBMC),
and considering the fact that this number re£ects the percentage
of PDC within all epidermal cells, including keratinocytes,
melanocytes, and others. Besides PDC, Langerhans cells and only
low numbers of IDEC were observed in LE (Fig 3A).
Next we studied the pro¢le of DC subsets in lesional skin of a
number of individual patients with AD (n¼ 9), psoriasis (n¼ 6),
CD (n¼ 5), and in skin from healthy donors (n¼ 3) (Fig 3).
PDC were absent in normal skin. The number of PDC was
signi¢cantly lower in skin samples from AD patients as
compared with skin samples from patients with psoriasis
(p¼ 0.02) and contact eczema (p¼ 0.02) (Fig 3C, left panel). In
contrast, high numbers of IDEC were found in all three
in£ammatory skin diseases, including AD; IDEC were low or
absent in normal skin (po0.05) (Fig 3C, middle panel).
Relatively high numbers of Langerhans cells were found in all
samples examined, including normal skin (Fig 3C, right panel).
The percentage of Langerhans cells among all lineage/MHC
IIþ cells, however, was signi¢cantly higher in normal skin as
compared with skin from patients with AD (p¼ 0.04).
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Comparing the number of PDC, IDEC, and Langerhans cells
within the di¡erent diagnoses (horizontal comparison), the
following signi¢cant di¡erences were found: in normal skin, the
percentage of Langerhans cells was higher than the percentage of
PDC (p¼ 0.04) or IDEC (p¼ 0.05). In samples from patients
with AD, the numbers of IDEC were higher than the number
of Langerhans cells (p¼ 0.02), and there were much more
Langerhans cells than PDC (po0.001). In patients with psoriasis,
PDC were always much lower than IDEC (p¼ 0.01) or
Langerhans cells (p¼ 0.04). Furthermore, in skin samples from
patients with CD, the numbers of IDEC were higher than PDC
(p¼ 0.03). Together these results revealed a distinct pro¢le of DC
subsets in lesions of di¡erent skin diseases. One of the most
intriguing observations was the relative absence of PDC in AD,
and the absence of PDC and IDEC in normal skin.
Localization of PDC in lesional skin BDCA-2 has been
reported to be selectively expressed on PDC (Dzionek et al,
2001). We used the BDCA-2 speci¢c MoAb to con¢rm the
presence of PDC in the basal epidermis and papillary dermis of
in£amed skin.We evaluated the use of this BDCA-2 antibody to
stain speci¢cally PDC in cryosections of human tonsils that
contain a relatively high number of PDC. As demonstrated in
Fig 4(A), staining of tonsillar cryosections with BDCA-2
antibodies revealed a considerable number of PDC in the area of
high endothelial venules and in the perifollicular T cell areas.
In agreement with our £ow cytometry studies, BDCA-2-
positive cells were absent in both epidermis and dermis of
healthy volunteers (not shown), supporting the PDC speci¢city
of the BDCA-2 antibodies (Dzionek et al, 2001).
In lesional skin of patients with psoriasis, BDCA-2-positive
cells were detected in the basal layer of the epidermis and the
papillary dermis (Fig 4B,C). In addition to providing
information on localization of PDC, immunohistochemistry
with BDCA-2 also con¢rmed our results of the presence of
PDC in in£ammatory skin lesions obtained by £ow cytometry.
Figure1. Identi¢cation of DC subsets in human skin. (A) Detection of myeloid DC and PDC in PBMC. PBMC isolated from peripheral blood of
healthy volunteers were stained with HLA-DR (PerCP), lineage markers (FITC), CD123 (PE), and CD11c (APC). A morphologic gate (FSC vs. SSC) was
set to exclude cell multiples from acquisition (not in ¢gure). HLA-DR+ and lineage^ cells were examined for the expression of CD11c (myeloid DC) and of
CD123 (PDC) by £ow cytometry. The FSC and SSC characteristics of PDC are indicated. (B) Detection of Langerhans cells and IDEC in normal and
in£ammatory skin and comparison of CD11b and CD11c expression. Epidermal single cell suspensions of biopsies of normal skin and of skin lesions of a
patient with AD were prepared and stained with CD1a (PE) in combination with either CD11b (FITC) or CD11c (FITC) (no additional staining with
lineage markers and HLA-DR). Langerhans cells both in normal and in£amed skin are identi¢ed by high expression of CD1a and the lack of CD11b. IDEC
identi¢ed by coexpression of CD1a and CD11b are detected in in£amed skin but not in normal skin. For both CD11b and CD11c, expression on IDEC is
higher than on Langerhans cells. (C) Simultaneous detection of PDC, IDEC, and Langerhans cells in in£amed skin: Epidermal single cell suspensions of
biopsies of skin lesions of a patient with psoriasis were prepared and stained with HLA-DR (PerCP), lineage markers (FITC), CD11c (APC), and either
CD123 (PE) or CD1a (PE). HLA-DR+ and lineage^ cells were gated and examined for the expression of CD123 (PDC) and CD11c (bright: IDEC; inter-
mediate/low: Langerhans cells). IDEC show a lower CD1a staining than Langerhans cells.The identity of PDC is con¢rmed by FSC and SSC characteristics
(cf. A).
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DISCUSSION
Langerhans cells play an established role as sentinels in normal
skin. Recent observations provide evidence that humans have dif-
ferent subsets of DC, which are specialized for the detection of
various pathogen-derived microbial molecules (Enk et al, 1993;
Krug et al, 2002b; Wollenberg et al, 2002). The immune system
seems to employ di¡erent DC subsets to trigger di¡erent sets of
immune responses appropriate for the defense against the corre-
sponding pathogens. In this study, we use a technique that allows
the simultaneous detection of PDC, IDEC, and Langerhans cells
in skin samples of di¡erent in£ammatory skin diseases. Our stu-
dies showed that PDC were as frequent in lesional skin of psor-
iasis, CD, and LE as in peripheral blood, whereas PDC were
reduced or absent in AD and in normal skin. PDC were localized
in the basal layer of the epidermis and the papillary dermis. High
numbers of IDEC were found in AD, psoriasis, and CD, whereas
IDEC were low or absent in LE and in normal skin. Langerhans
cells were found in all skin samples, but were highest in normal
skin.
Without clinical information such as the history and distribu-
tion pattern of the lesions, it is often di⁄cult to establish the cor-
rect diagnosis of in£ammatory skin diseases on histology alone.
Epidermal DC phenotyping has been reported to contribute to
the accurate diagnosis of in£ammatory skin diseases (Wollenberg
et al, 1995, 1999). In this study we demonstrate an improved tech-
nique that allows a quantitative assessment of Langerhans cells,
IDEC, and PDC in skin biopsies. Quanti¢cation of DC subsets
may help to distinguish lesional skin from AD, psoriasis, CD,
and normal skin.
PDC have been named DC2 based on studies demonstrating
that CD40 ligand-activated PDC promote T helper (Th)2 re-
sponses (Rissoan et al, 1999; Liu and Blom, 2000; Liu et al, 2000).
Others have questioned this view of PDC as DC2 by showing
that PDC stimulated by a virus can induce a Th1 response [IFN-
g4interleukin (IL)-4] or Th0 response (T cells that produce both
IFN-g and IL-10) (Cella et al, 2000; Kadowaki et al, 2000). PDC
express a limited toll like receptor (TLR) pro¢le, including
TLR9 (Krug et al, 2002b), which is known to be involved in the
recognition of CpG motifs within microbial DNA (Hartmann
and Krieg, 2000; Hemmi et al, 2000; Krug et al, 2001; Hornung
et al, 2002). There are hints that PDC may be involved in the
pathogenesis of autoimmune diseases (Ronnblom and Alm,
2001), allergy (Jahnsen et al, 2000), viral infections (Donaghy
et al, 2001; Feldman et al, 2001; Patterson et al, 2001), and cancer
(Zou et al, 2001).
It has been proposed that the phenotype of the epidermal DC
subsets may re£ect the disease-speci¢c microenvironment asso-
ciated with di¡erent disease entities and thus may provide addi-
tional information about the etiology of the disease (Wollenberg
et al, 1999). For example, the microenvironment of in£amed AD
skin, which is characterized by an increased production of Th2
cytokines (IL-4 and IL-13) in the acute skin lesions and is fre-
quently associated with an increased total serum IgE (Leung,
2000; Wollenberg et al, 2000), may account for the selective
lack of PDC in AD lesions. Th2 cytokines are thought to play
Figure 2. Comparison of BDCA-2 staining and CD123-based identi¢cation of PDC. Epidermal single cell suspensions of biopsies of lesional skin
were prepared. For the detection of PDC, a four-color staining protocol was used to identify DC subsets: HLA-DR (PerCP), lineage markers (FITC), CD11c
(APC), and CD123 (PE) (indicated as CD123+). Alternatively, HLA-DR (PerCP) staining was combined with the PDC-speci¢c anti-BDCA-2 antibody
(indicated as BDCA-2). (A) HLA-DR+ cells were gated and examined for the expression of BDCA-2. (B) The mean frequency of PDC in skin biopsies from
patients with AD (n¼ 3), psoriasis (n¼ 6), CD (n¼ 4), and LE (n¼ 2) is depicted (mean7SEM). The results with the two di¡erent staining protocols
(CD123 or BDCA-2) are compared, showing no statistical di¡erence between both methods.
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a part in the pathogenesis of AD by enhancing IgE synthesis,
eosinophilia, and induction of molecules that are involved in the
migration of in£ammatory cells into the skin lesions (Schleimer
et al, 1992; Akdis et al, 1997). Exposure of PDC to the Th2 cyto-
kine IL-4 leads to rapid cell death of PDC, an e¡ect that is poten-
tiated by IL-10, but blocked by CD40 ligand and IFN-g (Rissoan
et al, 1999). TheTh2 bias with increased IL-4 and decreased IFN-g
in the microenvironment of early AD lesions may induce cell
death in those PDC that in¢ltrate these areas. Despite the low
numbers of PDC found within the skin lesions, the number of
circulating PDC seems to be increased in patients with AD
(Uchida et al, 2001). One possible explanation for these seemingly
contradictory ¢ndings is that the increased number of circulating
PDC may compensate for the PDC loss in AD skin.
As PDC are regarded the key sensors of viral infection and
play an important part in the initiation of anti-viral immune re-
sponses by producing large amounts of the anti-viral cytokine
type I IFN (Cella et al, 1999), the lack of PDC in lesional skin of
AD patients is in good accordance with the clinically known pre-
disposition of atopic individuals to cutaneous infections.Whereas
nonatopics may easily clear human papillomavirus or molluscum
contagiosum virus infection from their skin by mounting anti-
viral immune responses employing their type I IFN producing
PDC, the impaired PDC recruitment of atopic individuals may
help to explain the long known susceptibility of atopic indivi-
duals to cutaneous infections. This concept ¢ts with our ¢nding
that disseminated skin infections with the herpes simplex virus
known as eczema herpeticum occurs almost exclusively in AD
patients (Bork and Brauninger, 1988; Wollenberg et al, 1997).
The impaired ability of AD patients to recruit PDC to their
skin lesions may be the immunologic basis for eczema herpeti-
cum, which still represents the most severe and feared complica-
tion of AD (Bork and Brauninger, 1988). Eczema herpeticum is
uncommon in patients with CD and psoriasis (Morganroth et al,
1992;Wollenberg et al, 1997), both of whom contain considerable
numbers of PDC in their skin lesions as demonstrated in this
study.
PDC are thought to play a speci¢c role in the pathogenesis of
LE, in which high systemic IFN-a levels are associated with dis-
ease activity (Ronnblom and Alm, 2001). We found a higher
Figure 3. PDC, Langerhans cells, and IDEC in normal skin and in lesional skin of patients with AD, psoriasis vulgaris, CD, and LE. Epider-
mal single cell suspensions of biopsies of normal skin and of lesional skin of patients with AD, psoriasis vulgaris, CD, and LE were prepared. (A) DC
subsets (PDC, IDEC, and Langerhans cells) were quanti¢ed by four-color-staining with HLA-DR (PerCP), lineage markers (FITC), CD11c (APC), and
CD123 (PE) as indicated. (B) The identity of PDC is con¢rmed by FSC and SSC characteristics as compared with PBMC (see Fig 1A). (C) The mean
frequencies of PDC, IDEC, and Langerhans cells (7SEM) are compared between normal skin (n¼ 3), AD (n¼ 9), psoriasis vulgaris (n¼ 6, patients not
identical with the six patients in Fig 2), and CD (n¼ 5). Note di¡erent scale of the x axis. Statistical signi¢cance was determined by Mann^Whitney U test
(npo0.05).
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frequency of PDC in the skin lesions of LE as compared with
peripheral blood. These results are in agreement with another
study, in which PDC were identi¢ed by immunohistochemical
staining (CD123 and CD45) in skin lesions of LE patients but
not in normal skin (Farkas et al, 2001). LE is an autoimmune dis-
order associated with anti-DNA antibodies and increased IFN-a/
b production. Anti-double-stranded DNA antibodies in combi-
nation with immunostimulatory plasmid DNA mimic the endo-
genous IFN-a inducer in systemic LE (Vallin et al, 1999). PDC
have been found to produce IFN-a in response to plasmid
DNA/anti-DNA antibody complexes (Dzionek et al, 2001).
With regard to the pathogenic role of PDC in di¡erent situa-
tions, besides viral infection, so far CpG DNA is the only de¢ned
microbial stimulus that is recognized by PDC (Kadowaki et al,
2001; Krug et al, 2002b). CpG DNA mimics the presence of mi-
crobial DNA, promoting survival and maturation of PDC (Hart-
mann et al, 1999), stimulates the production of IFN-a (Krug et al,
2002a) and IL-12 (Krug et al, 2002b), and promotes an IL-12-de-
pendent Th1 response. In the absence of the appropriate stimula-
tion, PDC are known to support a Th2 response (DC2)
(Kadowaki et al, 2000). Little is known about the properties of
PDC at e¡ector sites with direct antigen exposure, such as the
skin and mucosa. Synthetic CpG ODN might be useful to pro-
tect against viral infections such as eczema herpeticum by sup-
porting PDC survival and by inducing the production of Th1
cytokines IFN-a and IL-12 by PDC.
The regular presence of PDC in LE, psoriasis, and CD but
striking rareness of PDC in AD suggests a distinctive pathoge-
netic role of this cell type in in£ammatory skin diseases, which
provides a rationale why patients with AD show a predisposition
to viral skin infections, such as eczema herpeticum. The function
of the PDC with its speci¢c properties is likely to ¢ll some of the
gaps in our understanding of the pathophysiology of in£amma-
tory skin diseases. PDC may also be a novel target for the immu-
notherapy of such disorders.
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